{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T12:29:36Z","timestamp":1782476976237,"version":"3.54.5"},"reference-count":25,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2008.0599","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T09:11:18Z","timestamp":1525252278000},"source":"Crossref","is-referenced-by-count":4,"title":["Liquid Ecstasy \u2013 A Significant Drug Problem"],"prefix":"10.3238","author":[{"given":"Hilke","family":"Andresen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Stimpfl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Sprys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Schnitgerhans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2008,9,5]]},"reference":[{"key":"10.3238\/arztebl.2008.0599_ref1","unstructured":"European Monitoring Centre for Drugs and Drug Addiction: EMCDDA Thematic Papers \u2013 GHB and its precursor GBL: an emerging trend case study. 2008 ()"},{"key":"10.3238\/arztebl.2008.0599_ref2","doi-asserted-by":"crossref","unstructured":"Reeves J, Duda R: GHB\/GBL intoxication and withdrawal: a review and case presentation. Addictive Disorders & Their Treatment 2003; 2: 25\u20138.","DOI":"10.1097\/00132576-200302010-00005"},{"key":"10.3238\/arztebl.2008.0599_ref3","doi-asserted-by":"crossref","unstructured":"Couper FJ, Logan BK: Determination of gamma-hydroxybutyrate (GHB) in biological specimens by gas chromatography-mass spectrometry. J Anal Toxicol 2000; 24: 1\u20137.","DOI":"10.1093\/jat\/24.1.1"},{"key":"10.3238\/arztebl.2008.0599_ref4","doi-asserted-by":"crossref","unstructured":"Templeton A, Vonesch H-J: Intoxikation mit GHB (\u201eliquid ecstasy\u201c). Schweiz Med Forum 2005; 5: 115\u20136.","DOI":"10.4414\/smf.2005.05447"},{"key":"10.3238\/arztebl.2008.0599_ref5","doi-asserted-by":"crossref","unstructured":"Nightingale S: From the Food and Drug Administration (warning about GHB). J Am Med Assoc 1991; 265: 1802.","DOI":"10.1001\/jama.1991.03460140028006"},{"key":"10.3238\/arztebl.2008.0599_ref6","doi-asserted-by":"crossref","unstructured":"ElSohly MA, Salamone, SJ: Prevalence of drug used in cases of alleged sexual assault. J Anal Toxicol 1999; 23: 141\u20136.","DOI":"10.1093\/jat\/23.3.141"},{"key":"10.3238\/arztebl.2008.0599_ref7","doi-asserted-by":"crossref","unstructured":"Brenneisen R, ElSohly MA, Murphy TP, Passarelli J, Russmann S, Sala-mone SJ, Watson DE: Pharmacokinetics and excretion of gamma-hydroxybutyrate (GHB) in healthy subjects. J Anal Toxicol 2004; 28: 625\u201330.","DOI":"10.1093\/jat\/28.8.625"},{"key":"10.3238\/arztebl.2008.0599_ref8","doi-asserted-by":"crossref","unstructured":"Mazarr-Proo S, Kerrigan S: Distribution of GHB in tissues and fluids following a fatal overdose. J Anal Toxicol 2005; 29: 398\u2013400.","DOI":"10.1093\/jat\/29.5.398"},{"key":"10.3238\/arztebl.2008.0599_ref9","unstructured":"Fachinformation. Somsanit(R) Injektionsl\u00f6sung. K\u00f6hler Chemie GmbH Mai 2007."},{"key":"10.3238\/arztebl.2008.0599_ref10","doi-asserted-by":"crossref","unstructured":"Fuller D, Hornfeldt, C: From club drug to orphan drug: sodium oxybate (Xyrem) for the treatment of cataplexy. Pharmacotherapy 2003; 23: 1205\u20139.","DOI":"10.1592\/phco.23.10.1205.32756"},{"key":"10.3238\/arztebl.2008.0599_ref11","unstructured":"Fachinformation. Xyrem(R) 500mg\/ml L\u00f6sung zum Einnehmen. UCB Pharma Ltd Dez 2005."},{"key":"10.3238\/arztebl.2008.0599_ref12","doi-asserted-by":"crossref","unstructured":"Bernasconi R, Mathivet P, Bischoff S, Marescaux C: Gammahydroxybutyric acid: an endogenous neuromodulator with abuse potential? TiPS 1999; 20: 135\u201341.","DOI":"10.1016\/S0165-6147(99)01341-3"},{"key":"10.3238\/arztebl.2008.0599_ref13","unstructured":"Stein M: Stellungnahme zur nicht geringen Menge von Gamma-Hydroxybutters\u00e4ure. Toxichem und Krimtech 2003; 70: 87\u201392."},{"key":"10.3238\/arztebl.2008.0599_ref14","doi-asserted-by":"crossref","unstructured":"Drasbek K, Jensen JC: K. Gamma-hydroxybutyrate \u2013 a drug of abuse. Acta Neurol Scand 2006; 114: 145\u201356.","DOI":"10.1111\/j.1600-0404.2006.00712.x"},{"key":"10.3238\/arztebl.2008.0599_ref15","doi-asserted-by":"crossref","unstructured":"Maitre M: The gamma-hydroxybutyrate signalling system In Brain: Organization and functional implications. Progr Neurobiol 1997; 51: 337\u201361.","DOI":"10.1016\/S0301-0082(96)00064-0"},{"key":"10.3238\/arztebl.2008.0599_ref16","doi-asserted-by":"crossref","unstructured":"Palatini P, Tedeschi L, Frison G: Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers. European J Clin Pharmacol 1993; 45: 353\u20136.","DOI":"10.1007\/BF00265954"},{"key":"10.3238\/arztebl.2008.0599_ref17","doi-asserted-by":"crossref","unstructured":"Marinetti LJ, Isenschmid DS, Hepler BR, Kanluen S: Analysis of GHB and 4-methyl-GHB in postmortem matrices after long-term storage. J Anal Toxicol 2005; 29: 41\u20137.","DOI":"10.1093\/jat\/29.1.41"},{"key":"10.3238\/arztebl.2008.0599_ref18","doi-asserted-by":"crossref","unstructured":"Duer WC, Byers KL, Martin JV: Application of a convenient extraction procedure to analyze gamma-hydroxybutyric acid in fatalities involving gamma-hydroxybutyric acid, gamma-butyrolactone, and 1,4-butanediol. J Anal Toxicol 2001; 25: 576\u201382.","DOI":"10.1093\/jat\/25.7.576"},{"key":"10.3238\/arztebl.2008.0599_ref19","doi-asserted-by":"crossref","unstructured":"M\u00fchlendahl vKE, Oberdisse U, Bunjes R, Brockstedt M: Vergiftungen im Kindesalter. 4 Auflage. Stuttgart: Thieme Verlag 2003.","DOI":"10.1055\/b-002-54088"},{"key":"10.3238\/arztebl.2008.0599_ref20","doi-asserted-by":"crossref","unstructured":"Traub S, Nelson L, Hoffman R: Physostigmine as a treatment for gamma-hydroxybutyrate toxicity: a review. J Clin Toxicol 2002; 40: 781\u20137.","DOI":"10.1081\/CLT-120015839"},{"key":"10.3238\/arztebl.2008.0599_ref21","doi-asserted-by":"crossref","unstructured":"Galloway G, Frederick S, Staggers F, Gonzoles M, Stalcup S, Smith D: Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence. Addiction 1997; 92: 89\u201396.","DOI":"10.1111\/j.1360-0443.1997.tb03640.x"},{"key":"10.3238\/arztebl.2008.0599_ref22","doi-asserted-by":"crossref","unstructured":"Dyer JE, Roth B, Hyma B: Gamma-hydroxybutyrate withdrawal syndrome. Ann Emerg Med 2001; 37: 147\u201353.","DOI":"10.1067\/mem.2001.112985"},{"key":"10.3238\/arztebl.2008.0599_ref23","doi-asserted-by":"crossref","unstructured":"LeBeau MA, Andollo W, Hearn W et al.: Recommendation for toxicological investigations of drug-facilitated sexual assaults. J Forensic Sci 1999; 44: 227\u201330.","DOI":"10.1520\/JFS14442J"},{"key":"10.3238\/arztebl.2008.0599_ref24","unstructured":"European Monitoring Centre for Drugs and Drug Addiction: EMCDDA Technicla Datsheets \u2013 Sexual assaults facilitated by drugs or alcohol. 2008."},{"key":"10.3238\/arztebl.2008.0599_ref25","doi-asserted-by":"crossref","unstructured":"Crookes CE, Faulds MC, Forrest ARW, Galloway JH: A reference range for endogenous gamma-hydroxybutyrate in urine by gas chromatography-mass spectrometry. J Anal Toxicol 2004; 28: 644\u20139.","DOI":"10.1093\/jat\/28.8.644"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2008.0599","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T12:19:11Z","timestamp":1720268351000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2008.0599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,5]]},"references-count":25,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2008.0599","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,5]]}}}